Organogenesis Holdings Inc (NASDAQ: ORGO) kicked off on Monday, up 5.36% from the previous trading day, before settling in for the closing price of $2.80. Over the past 52 weeks, ORGO has traded in a range of $1.96-$4.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 19.04% over the last five years. While this was happening, its average annual earnings per share was recorded -283.23%. With a float of $77.76 million, this company’s outstanding shares have now reached $131.32 million.
The firm has a total of 862 workers. Let’s measure their productivity. In terms of profitability, gross margin is 72.43%, operating margin of 3.07%, and the pretax margin is -2.91%.
Organogenesis Holdings Inc (ORGO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Organogenesis Holdings Inc is 41.34%, while institutional ownership is 45.93%. The most recent insider transaction that took place on Jan 09 ’24, was worth 863,985. In this transaction 10% Owner of this company sold 197,921 shares at a rate of $4.37, taking the stock ownership to the 59,025,106 shares. Before that another transaction happened on Jan 10 ’24, when Company’s 10% Owner sold 17,972 for $4.28, making the entire transaction worth $76,875. This insider now owns 59,007,134 shares in total.
Organogenesis Holdings Inc (ORGO) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported 0.02 earnings per share (EPS), higher than consensus estimate (set at 0) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -283.23% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Take a look at Organogenesis Holdings Inc’s (ORGO) current performance indicators. Last quarter, stock had a quick ratio of 2.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.87. Likewise, its price to free cash flow for the trailing twelve months is 45.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.08 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Analysing the last 5-days average volume posted by the [Organogenesis Holdings Inc, ORGO], we can find that recorded value of 0.31 million was lower than the volume posted last year of 0.83 million. As of the previous 9 days, the stock’s Stochastic %D was 15.84%. Additionally, its Average True Range was 0.14.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 67.34%, which indicates a significant increase from 34.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.68% in the past 14 days, which was higher than the 56.56% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.87, while its 200-day Moving Average is $2.92. Now, the first resistance to watch is $3.00. This is followed by the second major resistance level at $3.06. The third major resistance level sits at $3.13. If the price goes on to break the first support level at $2.87, it is likely to go to the next support level at $2.80. Now, if the price goes above the second support level, the third support stands at $2.74.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
The company with the Market Capitalisation of 391.08 million has total of 132,572K Shares Outstanding. Its annual sales at the moment are 433,140 K in contrast with the sum of 4,950 K annual income. Company’s last quarter sales were recorded 130,230 K and last quarter income was -17,040 K.
